Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Fasudil Protects Against Adriamycin-induced Acute Heart Injury by Inhibiting Oxidative Stress, Apoptosis, and Cellular Senescence

Author(s): Yi Yan, Chengyu Xiang and Dingguo Zhang*

Volume 28, Issue 29, 2022

Published on: 25 August, 2022

Page: [2426 - 2435] Pages: 10

DOI: 10.2174/1381612828666220729103430

Price: $65

Abstract

Background: The clinical utility of Adriamycin (ADR) is limited due to its toxicity, particularly cardiotoxicity. Therefore, effective cardioprotective adjuvants to minimize ADR-induced acute cardiotoxicity are urgently needed. Our previous studies have demonstrated the protective roles of fasudil on tissue injury. Here, we further explore whether inhibition of Rho-kinase could alleviate the acute heart injury induced by ADR.

Methods: C57BL6 mice were randomly divided into the following four groups: ① ADR group; ② low-dose fasudil (ADR+L); ③ high-dose fasudil (ADR+H); and ④ control group (CON). Animals were injected i.p 20 mg/kg ADR once in group ①~③. Animals were injected i.p fasudil (2 or 10 mg/kg/day) daily for consecutive 6 days in groups ② and ③, respectively. Blood samples and heart tissues were collected for assays. H9C2 cells were treated with fasudil for 30 mins and then incubated with ADR for 24 hours. Cells were collected for immunohistochemistry and western blot study, respectively.

Results: In the mouse model, administration of fasudil significantly ameliorated ADR-induced cardiac damage, suppressed cell apoptosis and senescence, and ameliorated redox imbalance and DNA damage. In vitro, fasudil treatment ameliorated ADR-induced immunofluorescence reaction of 8-OHdG, decreased the expression of TUNEL cells and proteins of Bax, Caspase-3 and p53, and increased the expression of proteins of Bcl-2 and SIRT 1.

Conclusion: Fasudil has a protective effect on ADR induced acute cardiotoxicity, which is partially attributed to its antioxidant, anti-senescence, and anti-apoptotic effects.

Keywords: Adriamycin, fasudil, cardiotoxicity, apoptosis, senescence, oxidative stress.

« Previous
[1]
Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 2004; 110(18): 2869-74.
[http://dx.doi.org/10.1161/01.CIR.0000146889.46519.27] [PMID: 15505089]
[2]
Zakaria N, Khalil SR, Awad A, Khairy GM. Quercetin reverses altered energy metabolism in the heart of rats receiving adriamycin chemotherapy. Cardiovasc Toxicol 2018; 18(2): 109-19.
[http://dx.doi.org/10.1007/s12012-017-9420-4] [PMID: 28702745]
[3]
Wang N, Guan P, Zhang JP, et al. Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA/ROCK pathway. Food Chem Toxicol 2011; 49(11): 2975-82.
[http://dx.doi.org/10.1016/j.fct.2011.06.080] [PMID: 21803115]
[4]
Bose C, Awasthi S, Sharma R, et al. Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. PLoS One 2018; 13(3): e0193918.
[http://dx.doi.org/10.1371/journal.pone.0193918] [PMID: 29518137]
[5]
Thandavarayan RA, Watanabe K, Sari FR, et al. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Free Radic Biol Med 2010; 49(9): 1422-31.
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.08.005] [PMID: 20705132]
[6]
Dai GF, Wang Z, Zhang JY. Octreotide protects doxorubicin-induced cardiac toxicity via regulating oxidative stress. Eur Rev Med Pharmacol Sci 2018; 22(18): 6139-48.
[PMID: 30280802]
[7]
Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 2012; 52(6): 1213-25.
[http://dx.doi.org/10.1016/j.yjmcc.2012.03.006] [PMID: 22465037]
[8]
Xia P, Liu Y, Chen J, Coates S, Liu DX, Cheng Z. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy. J Biol Chem 2018; 293(51): 19672-85.
[http://dx.doi.org/10.1074/jbc.RA118.004673] [PMID: 30361442]
[9]
Li T, Singal PK. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000; 102(17): 2105-10.
[http://dx.doi.org/10.1161/01.CIR.102.17.2105] [PMID: 11044428]
[10]
Pereira GC, Silva AM, Diogo CV, Carvalho FS, Monteiro P, Oliveira PJ. Drug-induced cardiac mitochondrial toxicity and protection: From doxorubicin to carvedilol. Curr Pharm Des 2011; 17(20): 2113-29.
[http://dx.doi.org/10.2174/138161211796904812] [PMID: 21718248]
[11]
Fang J, Tang Y, Cheng X, et al. Exenatide alleviates adriamycin-induced heart dysfunction in mice: Modulation of oxidative stress, apoptosis and inflammation. Chem Biol Interact 2019; 304: 186-93.
[http://dx.doi.org/10.1016/j.cbi.2019.03.012] [PMID: 30885636]
[12]
Sung JY, Lee KY, Kim JR, Choi HC. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through] decreased expressions of p53/p21/p16. Exp Gerontol 2018; 109: 51-8.
[http://dx.doi.org/10.1016/j.exger.2017.08.001] [PMID: 28797827]
[13]
You R, Dai J, Zhang P, Barding GA Jr, Raftery D. Dynamic metabolic response to adriamycin-induced senescence in breast cancer cells. Metabolites 2018; 8(4): E95.
[http://dx.doi.org/10.3390/metabo8040095] [PMID: 30558288]
[14]
Song X, He R, Han W, et al. Protective effects of the ROCK inhibitor fasudil against cognitive dysfunction following status epilepticus in male rats. J Neurosci Res 2018.
[PMID: 30421453]
[15]
Wang Y, Zhang H, Yang Z, Miao D, Zhang D. Rho kinase inhibitor, fasudil, attenuates contrast-induced acute kidney injury. Basic Clin Pharmacol Toxicol 2018; 122(2): 278-87.
[http://dx.doi.org/10.1111/bcpt.12895] [PMID: 28929640]
[16]
Yan Y, Xiang C, Yang Z, Miao D, Zhang D. Rho kinase inhibition by fasudil attenuates adriamycin-induced chronic heart injury. Cardiovasc Toxicol 2020; 20(4): 351-60.
[http://dx.doi.org/10.1007/s12012-019-09561-6] [PMID: 31894538]
[17]
Zhao Y, Zhang Y, Vazirinejad Mehdiabad M, et al. Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo. PLoS One 2019; 14(10): e0223232.
[http://dx.doi.org/10.1371/journal.pone.0223232] [PMID: 31581236]
[18]
Huang YY, Wu JM, Su T, Zhang SY, Lin XJ. Fasudil, a rho-kinase inhibitor, exerts cardioprotective function in animal models of myocardial ischemia/reperfusion injury: A meta-analysis and review of preclinical evidence and possible mechanisms. Front Pharmacol 2018; 9: 1083.
[http://dx.doi.org/10.3389/fphar.2018.01083] [PMID: 30327600]
[19]
Guan P, Liang Y, Wang N. Fasudil alleviates pressure overload-induced heart failure by activating Nrf2-mediated antioxidant responses. J Cell Biochem 2018; 119(8): 6452-60.
[http://dx.doi.org/10.1002/jcb.26662] [PMID: 29323739]
[20]
Wu N, Li W, Shu W, Lv Y, Jia D. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart. Mol Med Rep 2014; 10(5): 2517-24.
[http://dx.doi.org/10.3892/mmr.2014.2566] [PMID: 25231456]
[21]
Chen H, Gao L, Huang Z, et al. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT. Life Sci 2018; 207: 492-8.
[http://dx.doi.org/10.1016/j.lfs.2018.06.029] [PMID: 29964055]
[22]
Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349(9058): 1050-3.
[http://dx.doi.org/10.1016/S0140-6736(96)07015-8] [PMID: 9107242]
[23]
El-Boghdady NA. Increased cardiac endothelin-1 and nitric oxide in adriamycin-induced acute cardiotoxicity: Protective effect of Ginkgo biloba extract. Indian J Biochem Biophys 2013; 50(3): 202-9.
[PMID: 23898483]
[24]
Mohamad RH, El-Bastawesy AM, Zekry ZK, et al. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food 2009; 12(2): 394-402.
[http://dx.doi.org/10.1089/jmf.2007.0715] [PMID: 19459743]
[25]
Liu ML, Wang ML, Lv JJ, Wei J, Wan J. Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats. Exp Ther Med 2018; 15(4): 3425-31.
[http://dx.doi.org/10.3892/etm.2018.5862] [PMID: 29545864]
[26]
Aniss HA, Said Ael M, El Sayed IH, Adly C. Amelioration of adriamycin-induced cardiotoxicity by Salsola kali aqueous extract is mediated by lowering oxidative stress. Redox report : Communications in free radical research 2014; 19(4): 170-8.
[27]
Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15(4): 316-28.
[http://dx.doi.org/10.1016/j.numecd.2005.05.003] [PMID: 16054557]
[28]
Ozdogan K, Taskin E, Dursun N. Protective effect of carnosine on adriamycin-induced oxidative heart damage in rats. Anadolu kardiyoloji dergisi: AKD = the Anatolian journal of cardiology 2011; 11(1): 3-10.
[http://dx.doi.org/10.5152/akd.2011.003]
[29]
Zhang XH, Feng ZH, Wang XY. The ROCK pathway inhibitor Y-27632 mitigates hypoxia and oxidative stress-induced injury to retinal Müller cells. Neural Regen Res 2018; 13(3): 549-55.
[http://dx.doi.org/10.4103/1673-5374.228761] [PMID: 29623943]
[30]
Liang J, Zeng X, Halifu Y, et al. Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway. Mol Cell Biochem 2017; 436(1-2): 151-8.
[http://dx.doi.org/10.1007/s11010-017-3086-x] [PMID: 28608226]
[31]
Lee D, Goldberg AL. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem 2013; 288(42): 30515-26.
[http://dx.doi.org/10.1074/jbc.M113.489716] [PMID: 24003218]
[32]
Lin CH, Lin CC, Ting WJ, et al. Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts. Age (Dordr) 2014; 36(5): 9705.
[http://dx.doi.org/10.1007/s11357-014-9705-5] [PMID: 25158994]
[33]
Oka S, Alcendor R, Zhai P, et al. PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab 2011; 14(5): 598-611.
[http://dx.doi.org/10.1016/j.cmet.2011.10.001] [PMID: 22055503]
[34]
Guo RM, Xu WM, Lin JC, et al. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol Med Rep 2013; 8(2): 603-8.
[http://dx.doi.org/10.3892/mmr.2013.1554] [PMID: 23807148]
[35]
Kannappan R, Mattapally S, Wagle PA, Zhang J. Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells. Am J Physiol Heart Circ Physiol 2018; 315(3): H512-21.
[http://dx.doi.org/10.1152/ajpheart.00160.2018] [PMID: 29775409]
[36]
He L, Xiao J, Fu H, et al. Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 2012; 32(3): 334-9.
[http://dx.doi.org/10.1007/s11596-012-0058-y]
[37]
Abd El-Aziz TA, Mohamed RH, Pasha HF, Abdel-Aziz HR. Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin Exp Med 2012; 12(4): 233-40.
[http://dx.doi.org/10.1007/s10238-011-0165-2] [PMID: 22080234]
[38]
Preau S, Delguste F, Yu Y, et al. Endotoxemia engages the RhoA kinase pathway to impair cardiac function by altering cytoskeleton, mitochondrial fission, and autophagy. Antioxid Redox Signal 2016; 24(10): 529-42.
[http://dx.doi.org/10.1089/ars.2015.6421] [PMID: 26602979]
[39]
Hattori T, Shimokawa H, Higashi M, et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 2004; 109(18): 2234-9.
[http://dx.doi.org/10.1161/01.CIR.0000127939.16111.58] [PMID: 15096457]
[40]
Lv X, Yu X, Wang Y, et al. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One 2012; 7(10): e47351.
[http://dx.doi.org/10.1371/journal.pone.0047351] [PMID: 23077597]
[41]
Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 2002; 62(16): 4592-8.
[PMID: 12183413]
[42]
Jing X, Yang J, Jiang L, Chen J, Wang H. MicroRNA-29b regulates the mitochondria-dependent apoptotic pathway by targeting bax in doxorubicin cardiotoxicity. Cellular physiology and biochemistry : International journal of experimental cellular physiology, biochemistry, and pharmacology 2018; 48(2): 692-704.
[http://dx.doi.org/10.1159/000491896]
[43]
Bao YL, Wang Y, Wu Z, et al. Effects of caspase inhibitor z- VAD-fmk on the expressions of calumenin, caspase-3, GRP78 and GRP94 in adriamycin-injured cardiomyocytes. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 2017; 33(3): 222-5.
[44]
Yanagi S, Matsumura K, Marui A, et al. Oral pretreatment with a green tea polyphenol for cardioprotection against ischemia-reperfusion injury in an isolated rat heart model. J Thorac Cardiovasc Surg 2011; 141(2): 511-7.
[http://dx.doi.org/10.1016/j.jtcvs.2010.04.016] [PMID: 20546800]
[45]
Wilcox NS, Rotz SJ, Mullen M, et al. Sex-specific cardiovascular risks of cancer and its therapies. Circ Res 2022; 130(4): 632-51.
[http://dx.doi.org/10.1161/CIRCRESAHA.121.319901] [PMID: 35175846]
[46]
Meiners B, Shenoy C, Zordoky BN. Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. Biol Sex Differ 2018; 9(1): 38.
[http://dx.doi.org/10.1186/s13293-018-0198-2] [PMID: 30157941]
[47]
Ojeda NB, Royals TP, Alexander BT. Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: Role of fasudil, a Rho kinase inhibitor. Am J Physiol Renal Physiol 2013; 304(7): F900-7.
[http://dx.doi.org/10.1152/ajprenal.00687.2012] [PMID: 23344570]

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy